CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease.
Elbaz A., Levecque C., Clavel J., Vidal J-S., Richard F., Amouyel P., Alpérovitch A., Chartier-Harlin M-C., Tzourio C.
We performed a case-control study of Parkinson's disease (PD) in a population characterized by a high prevalence of pesticide exposure and studied the joint effect of pesticide exposure and CYP2D6. Although they are based on a small group of subjects with the joint exposure, our findings are consistent with a gene-environment interaction disease model according to which (1) pesticides have a modest effect in subjects who are not CYP2D6 poor metabolizers, (2) pesticides' effect is increased in poor metabolizers (approximately twofold), and (3) poor metabolizers are not at increased PD risk in the absence of pesticide exposure.